ISPOR 3rd ASIA-PACIFIC CONFERENCE AWARDS WINNERS

By Stephen Priori

The ISPOR Best Podium and Poster Presentation Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, and Asia-Pacific Conferences.

During the ISPOR 3rd Asia-Pacific Conference, 7-9 September 2008, Grand Hilton Seoul, Seoul, Korea. the scientific merit exhibited in the poster and podium presentations were judged with awards to be given by authors’ classifications of a general category for both. This year the ISPOR Awards Committee evaluated 40 podium presentations and over 120 poster presentations.

Evaluations of scientific merit were based upon the following criteria:

Background provides appropriate perspective / context for the subject
Objectives / research questions are clearly stated
Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
Data sources and/or sampling procedures are clear and appropriate
Data analyses are appropriate
Research objectives are met/addressed
Implications of findings are discussed
Factual information is kept separate from interpretations or implications
Abstract is presented in an unbiased manner
Clarity of presentation

THE RECIPIENTS ARE: . . .

ISPOR Best Podium Research Presentation Awards

CE3
COST-EFFECTIVENESS OF SMOKING CESSATION IN AUSTRALIA WITH VARENICLINE, A NOVEL PHARMACOTHERAPY
Brown A¹, Webb K², Kim H³, Liew D⁴
¹Pfizer Australia Pty Limited, West Ryde, NSW, Australia, ²Pfizer Inc, Tadworth, Surrey, United Kingdom, ³Pfizer Inc, Sydney, NSW, Australia, ⁴University of Melbourne, Melbourne, Victoria, Australia

CH3
ECONOMIC BURDEN OF SMOKING IN CHINA
Li L¹, Chen Q¹, Cui X¹, Yu J¹, Jia R²
¹Peking University, Beijing, China, ²Stockholm University, Stockholm, Sweden

JA3
COST-EFFECTIVENESS ANALYSIS OF SCREENING FOR IRON-DEFICIENCY ANEMIA IN MIDDLE-AGED WOMEN IN JAPAN
Sakai M¹²³, Shimbo T¹, Takahashi Y¹
¹Department of Clinical Research and Informatics, Research Institute, International Medical Center of Japan, Tokyo, Japan; ²Department of Epidemiology and Healthcare research, Kyoto University School of Public Health, Kyoto, Japan; ³Center for Health Service, Outcomes Research and Development - Japan (CHORD-J), Tokyo, Japan

	KO3 HEALTH STATE UTILITY ASSESSMENT BY EQ5D IN CHRONIC HEPATITIS B PATIENTS IN KOREA Lee YR¹, Kwon SY², Lee YS³, Lee JH⁴, Choi HM¹, Lee CH² ¹GlaxoSmithKline, Seoul, South Korea, ²Konkuk University, Seoul, South Korea, ³Catholic University of Korea, Bucheon, South Korea, ⁴Sungkyunkwan University, Seoul, South Korea
	PR2 HEALTH RELATED QUALITY OF LIFE AND ITS ASSOCIATED FACTORS IN PATIENTS WITH TYPE 2 DIABETES IN SOUTH KOREA Jo MW¹, Lee WJ², Noh JH³, Song KH⁴, Choi YJ⁵ ¹Dongguk University, Gyeongju, Gyeongbuk, South Korea, ²Inje University Sanggye Paik Hospital, Seoul, South Korea, ³Inje University Ilsan Paik Hospital, Ilsan, Gyeonggi-Do, South Korea, ⁴Kunkuk University Hospital, Seoul, South Korea, ⁵Sanofi-Aventis Korea, Seoul, South Korea
	TH3 COST-UTILITY ANALYSIS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN CANCER PATIENTS WITH ANEMIA INDUCED BY CHEMOTHERAPY IN THAILAND Roungrong J¹, Teerawattananon Y¹, Chaikledkaew U² ¹Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, ²Faculty of Pharmacy Mahidol University, Ratchathewi, Bangkok, Thailand

ISPOR Best Poster Research Presentation Awards

PDB9
INCREMENTAL TREATMENT COSTS ATTRIBUTABLE TO OBESITY IN PATIENTS WITH DIABETES MELLITUS IN THE U.S.
Suh DC¹, Jang EJ¹, Kim CM², Jung JC³, Jang SM⁴
1Rutgers University, Piscataway, NJ, USA, 2Catholic University, Seoul, Suhcho-gu, South Korea, 3Korea National Health Insurance Corporation, Mapo-gu, Seoul, South Korea, ⁴Health Insurance Review & Assessment Service, Seoul, South Korea

PDB10
EFFECT OF ANTIHYPERGLYCEMIC MEDICATION ADHERENCE ON HOSPITALIZATION AND HEALTHCARE COST
Jang SM¹, Park IB², Suh DC³, Moon KT⁴, Kim CM⁵, Kim JY⁴
¹Health Insurance Review & Assessment Service, Seoul, South Korea, ²Gachon University, Incheon, Incheon, South Korea, ³Rutgers University, Piscataway, NJ, USA, ⁴Health Insurance Review & Assessment Service, Seoul, Seoul, South Korea, 5Catholic University, Seoul, Suhcho-gu, South Korea

PGI3
VALIDITY OF THE KOREAN VERSION OF THE CHRONIC LIVER DISEASE QUESTIONNAIRE (CLDQ) FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN KOREAN PATIENTS WITH CHRONIC HEPATITIS B
Choi HM¹, Kwon SY², Kim Y¹, Koo HW¹, Choi W¹, Lee YS¹, Lee YS³, Lee JH⁴, Lee CH²
¹GlaxoSmithKline, Seoul, South Korea, ²Konkuk University, Seoul, South Korea, ³Catholic University of Korea, Bucheon, South Korea, ⁴Sungkyunkwan University, Seoul, South Korea

	PHP11 PRINCIPAL COMPONENTS ANALYSIS OF DRUG UTILIZATION AND EXPENDITURE TRENDS FOR MAJOR THERAPEUTIC CLASSES IN U.S. MEDICAID PROGRAMS Jing Y¹, Nguyen K¹, Fan H², Kelton CM¹, Li X³, Guo JJ¹ ¹University of Cincinnati, Cincinnati, OH, USA, ²Covance Inc, Sun Prairie, WI, USA
	PMS5 ECONOMIC EVALUATION ON SCREENING STRATEGIES AND TREATMENT OPTIONS FOR POSTMENOPAUSAL OSTEOPOROSIS Kingkaew P¹, Maleewong U², Ngarmukos C³, Teerawattananon Y¹ ¹Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand, ²Mahasarakham University, Mahasarakham, Thailand, ³Ramathibodi Hospital, Bangkok, Thailand
	PRS6 COST-EFFECTIVENESS ANALYSIS OF SMOKING CESSATION PHARMACOTHERAPIES IN AUSTRALIA Bhatti TA¹, Makino K¹, Guarnieri C¹, Gordois A¹, Cotter T², Perez DA², Bishop JF², Glass P², Fong L¹ ¹IMS Health, St Leonards, New South Wales, Australia, ²Cancer Institute NSW, Eveleigh, New South Wales, Australia

ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster presentations.